旭富製藥科技股份有限公司
旭富製藥科技股份有限公司（SCI Pharmtech, Inc.）研發、製造並銷售原料藥（API）、中間體及特用化學品。提供心血管、憂鬱症、及痛風藥物原料，並提供客製化研發製造服務。公司成立於 1987 年，總部位於台灣桃園。
該股 RSI(6) 為 38.9，處於中性區間，短線無明顯超買超賣訊號。股價站上60日、120日均線，跌破5日、20日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標中性（K=29.2）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -49 | 0 | 0 | -48 |
| 09-23 | -3 | 0 | 0 | -3 |
| 09-22 | +15 | 0 | 0 | +15 |
| 09-21 | -16 | 0 | +1 | -15 |
| 09-18 | -14 | 0 | +6 | -8 |
| 09-17 | +15 | 0 | +1 | +16 |
| 09-16 | -28 | 0 | +2 | -26 |
| 09-15 | +68 | 0 | +3 | +71 |
| 09-14 | -5 | 0 | -3 | -8 |
| 09-11 | +19 | 0 | -4 | +15 |
| 09-10 | +15 | 0 | +1 | +16 |
| 09-09 | +164 | 0 | -3 | +161 |
| 09-08 | -51 | 0 | -4 | -55 |
| 09-07 | -3 | 0 | +5 | +2 |
| 09-04 | -93 | 0 | +1 | -92 |
| 09-03 | -82 | 0 | 0 | -82 |
| 09-02 | -22 | 0 | +1 | -21 |
| 09-01 | +62 | 0 | -9 | +53 |
| 08-31 | +58 | 0 | 0 | +58 |
| 08-28 | -1 | 0 | +5 | +4 |
| 08-27 | +74 | 0 | -4 | +71 |
| 08-26 | -11 | 0 | +8 | -3 |
| 08-25 | -43 | 0 | 0 | -43 |
| 08-24 | +1 | 0 | 0 | +1 |
| 08-21 | -13 | 0 | +6 | -7 |
| 08-20 | +33 | 0 | 0 | +32 |
| 08-19 | -19 | 0 | 0 | -19 |
| 08-18 | +28 | 0 | 0 | +28 |
| 08-17 | +18 | 0 | +3 | +21 |
| 08-14 | -156 | 0 | +1 | -155 |
| 08-13 | -68 | 0 | 0 | -68 |
| 08-12 | +255 | 0 | +3 | +258 |
| 08-11 | +2 | 0 | +1 | +3 |
| 08-10 | -119 | 0 | 0 | -119 |
| 08-07 | +152 | 0 | -5 | +147 |
| 08-06 | -34 | 0 | -12 | -46 |
| 08-05 | +2 | 0 | 0 | +2 |
| 08-04 | +3 | 0 | -18 | -16 |
| 08-03 | +3 | 0 | -3 | 0 |
| 07-31 | -74 | 0 | +10 | -64 |
| 07-30 | +28 | 0 | -6 | +22 |
| 07-29 | +118 | 0 | +18 | +136 |
| 07-28 | -21 | 0 | 0 | -21 |
| 07-27 | -60 | 0 | +3 | -57 |
| 07-24 | +227 | 0 | -7 | +220 |
| 07-23 | -34 | 0 | 0 | -34 |
| 07-22 | -5 | 0 | -3 | -8 |
| 07-21 | +84 | 0 | -5 | +79 |
| 07-20 | +20 | 0 | +4 | +24 |
| 07-17 | -24 | 0 | +1 | -23 |
| 07-16 | +27 | 0 | +2 | +29 |
| 07-15 | +51 | 0 | -5 | +46 |
| 07-14 | +23 | 0 | +6 | +29 |
| 07-13 | +15 | 0 | +3 | +18 |
| 07-09 | +17 | 0 | -4 | +13 |
| 07-08 | +21 | 0 | -1 | +20 |
| 07-07 | -27 | 0 | 0 | -27 |
| 07-06 | +3 | 0 | 0 | +3 |
| 07-03 | +7 | 0 | -1 | +6 |
| 07-02 | +75 | 0 | -9 | +66 |
| 07-01 | -32 | 0 | +1 | -31 |
| 06-30 | -16 | 0 | -1 | -17 |
| 06-29 | -4 | 0 | +1 | -3 |
| 06-26 | -58 | 0 | 0 | -58 |
| 06-25 | +3 | 0 | 0 | +3 |
| 06-24 | +56 | 0 | -1 | +55 |
| 06-22 | -50 | 0 | -1 | -51 |
| 06-18 | -35 | 0 | -1 | -36 |
| 06-17 | +96 | 0 | -1 | +95 |
| 06-16 | +53 | 0 | +1 | +54 |
| 06-15 | -49 | 0 | +12 | -37 |
| 06-12 | -84 | 0 | +2 | -82 |
| 06-10 | -188 | 0 | +3 | -185 |
| 06-09 | -327 | 0 | -2 | -329 |
| 06-08 | +41 | 0 | -2 | +39 |
| 06-04 | -19 | 0 | +2 | -17 |
| 06-03 | +44 | 0 | -6 | +38 |
| 06-02 | -19 | 0 | -1 | -20 |
| 06-01 | +107 | 0 | 0 | +107 |
| 05-29 | +25 | 0 | 0 | +25 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 1.49 億 | -21.9% | +187.5% |
| 2026/07 | 1.91 億 | +54.8% | +133.2% |
| 2026/06 | 1.23 億 | +102.3% | +36.1% |
| 2026/05 | 6093 萬 | -31.3% | -47.1% |
| 2026/04 | 8870 萬 | -30.5% | -46.5% |
| 2026/03 | 1.28 億 | +7.7% | -24.4% |
| 2026/02 | 1.19 億 | -8.6% | +39.9% |
| 2026/01 | 1.30 億 | -14.5% | +21.4% |
| 2025/12 | 1.52 億 | +46.7% | +94.5% |
| 2025/11 | 1.03 億 | +2.9% | -33.5% |
| 2025/10 | 1.00 億 | -18.2% | -40.3% |
| 2025/09 | 1.23 億 | - | -7.2% |